Does Risperdal Cause Gynecomastia?
Yes, Risperdal (risperidone) causes gynecomastia—enlarged breast tissue in males—by elevating prolactin levels, a hormone that stimulates breast growth. This side effect occurs in about 1-5% of patients, more commonly in adolescents and young males, with cases reported across clinical trials and post-marketing surveillance.[1][2]
How Does Risperidone Trigger This?
Risperidone blocks dopamine D2 receptors in the pituitary gland, reducing dopamine's inhibition of prolactin release. Elevated prolactin (hyperprolactinemia) leads to gynecomastia, galactorrhea (milk production), and sometimes sexual dysfunction. Unlike typical antipsychotics, risperidone has high potency for this effect, with prolactin levels rising dose-dependently—often 4-10 times normal within weeks.[3][4]
Who Gets It and How Common?
Risk is highest in males under 25, with incidence up to 10% in pediatric studies versus under 1% in adults. A 2010 FDA analysis of 49 cases found most involved boys aged 9-14 on doses over 2mg/day. Long-term use (over 6 months) increases odds; symptoms may persist after stopping.[1][5]
What Do Studies and FDA Warnings Say?
- Clinical trials: Janssen's trials showed gynecomastia in 2.6% of risperidone users vs. 0.7% placebo.[2]
- FDA black box: Warns of hyperprolactinemia; 2006 label update mandated prolactin monitoring.[6]
- Lawsuits: Over 13,000 U.S. claims allege J&J failed to disclose risks, resulting in $2.6B+ settlements (e.g., 2013 Texas case).[7]
Reversibility and Management
Gynecomastia often reverses within months of dose reduction or switching to aripiprazole (lower prolactin risk). Surgery is rare but needed for severe, persistent cases. Monitor prolactin if symptoms appear; baseline levels help track changes.[4][8]
Alternatives with Lower Gynecomastia Risk
| Drug | Prolactin Effect | Gynecomastia Rate |
|------|------------------|-------------------|
| Aripiprazole (Abilify) | Minimal rise | <1%[9] |
| Quetiapine (Seroquel) | Low | 0.5-1%[10] |
| Olanzapine (Zyprexa) | Moderate | 1-2%[3] |
| Haloperidol | High (worse than risperidone) | 5-10%[4] |
Sources
[1]: FDA Risperdal Label
[2]: Janssen Clinical Data
[3]: NEJM Review on Antipsychotics
[4]: PubMed: Risperidone and Prolactin
[5]: FDA Adverse Event Report
[6]: FDA 2006 Update
[7]: Reuters: Risperdal Settlements
[8]: APA Guidelines
[9]: Abilify Label
[10]: Seroquel Label